Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)
about
A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide HydrolaseFatty acid amide hydrolase inhibitors: a patent review (2009-2014)Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding PocketsApproximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH)α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase.The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolaseBiphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stabilitySecretion, isotopic labeling and deglycosylation of N-Acylethanolamine acid amidase for biophysical studies.N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
P2860
Q27675504-E601A813-4BA0-4753-9160-7953F19F7749Q28267884-76AFC034-7598-4392-B116-487FDDB99524Q28548681-97A9CF73-8933-489A-B4E6-40F9F71D8FF3Q28740837-55C08C9A-8CF2-4ACA-827F-32548D0DBA9EQ33644120-52DE0001-0728-428A-B251-C3A0C29729B0Q33684510-058BA42B-61F8-4B27-A00F-3B3AD2D8979BQ34027721-78F4318F-8544-4230-9550-37ECF9EB7168Q34461976-90DDDA75-3979-419D-9AB1-A6ED6E847427Q36727793-438C9D65-AC0C-4BFB-A0D9-CE7605B97777Q37613654-CAE14151-8355-43B9-86DF-E6F3E4941B1BQ41785885-FFBB2491-4CB4-471E-8656-213051ACF1C4Q47280730-5DBFB102-8D10-4A74-98E7-B4D1063D9192Q53554218-5D169DF5-085F-4AF1-8A6C-663914342307
P2860
Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@ast
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@en
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@nl
type
label
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@ast
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@en
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@nl
prefLabel
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@ast
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@en
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@nl
P2093
P2860
P356
P1476
Discovery and molecular basis ...... ty acid amide hydrolase (FAAH)
@en
P2093
Amy C Porter
Craig Uyeda
Darin J Gustin
Frank Kayser
Michelle Lindstrom
Nigel P C Walker
Stephen T Thibault
Timothy J Carlson
P2860
P304
P356
10.1073/PNAS.1016167108
P407
P50
P577
2011-04-18T00:00:00Z